oxidopamine has been researched along with Marasmus in 2 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Schlesinger, L | 1 |
Arevalo, M | 1 |
Simon, V | 1 |
Lopez, M | 1 |
Muñoz, C | 1 |
Hernandez, A | 1 |
Carreño, P | 1 |
Belmar, J | 1 |
White, A | 1 |
Häffner-Cavaillon, N | 1 |
González-Ariki, S | 1 |
Husband, AJ | 1 |
2 other studies available for oxidopamine and Marasmus
Article | Year |
---|---|
Immune depression induced by protein calorie malnutrition can be suppressed by lesioning central noradrenaline systems.
Topics: Animals; Brain; Corticosterone; Female; Immune Tolerance; Interleukin-1; Lymphocyte Activation; Medi | 1995 |
Sympathectomy abrogates immunodeficiency associated with protein-energy malnutrition.
Topics: Animals; Female; Immunoglobulin A; Immunologic Deficiency Syndromes; Injections, Intraperitoneal; In | 1999 |